Thun, G.A.* ; Imboden, M.* ; Ferrarotti, I.* ; Kumar, A.* ; Obeidat, M.* ; Zorzetto, M.* ; Haun, M.* ; Curjuric, I.* ; Couto Alves, A.* ; Jackson, V.E.* ; Albrecht, E. ; Ried, J.S. ; Teumer, A.* ; Lopez, L.M.* ; Huffman, J.E.* ; Enroth, S.* ; Bossé, Y.* ; Hao, K.* ; Timens, W.* ; Gyllensten, U.* ; Polasek, O.* ; Wilson, J.F.* ; Rudan, I.* ; Hayward, C.* ; Sandford, A.J.* ; Deary, I.J.* ; Koch, B.* ; Reischl, E. ; Schulz, H. ; Hui, J.* ; James, A.L.* ; Rochat, T.* ; Russi, E.W.* ; Jarvelin, M.R.* ; Strachan, D.P.* ; Hall, I.P.* ; Tobin, M.D.* ; Dahl, M.* ; Fallgaard Nielsen, S.* ; Nørdestgaard, B.G.* ; Kronenberg, F.* ; Luisetti, M.* ; Probst-Hensch, N.M.*
Causal and synthetic associations of variants in the SERPINA gene cluster with alpha1-antitrypsin serum levels.
PLoS Genet. 9:e1003585 (2013)
Several infrequent genetic polymorphisms in the SERPINA1 gene are known to substantially reduce concentration of alpha1-antitrypsin (AAT) in the blood. Since low AAT serum levels fail to protect pulmonary tissue from enzymatic degradation, these polymorphisms also increase the risk for early onset chronic obstructive pulmonary disease (COPD). The role of more common SERPINA1 single nucleotide polymorphisms (SNPs) in respiratory health remains poorly understood. We present here an agnostic investigation of genetic determinants of circulating AAT levels in a general population sample by performing a genome-wide association study (GWAS) in 1392 individuals of the SAPALDIA cohort. Five common SNPs, defined by showing minor allele frequencies (MAFs) >5%, reached genome-wide significance, all located in the SERPINA gene cluster at 14q32.13. The top-ranking genotyped SNP rs4905179 was associated with an estimated effect of β = -0.068 g/L per minor allele (P = 1.20*10(-12)). But denser SERPINA1 locus genotyping in 5569 participants with subsequent stepwise conditional analysis, as well as exon-sequencing in a subsample (N = 410), suggested that AAT serum level is causally determined at this locus by rare (MAF<1%) and low-frequent (MAF 1-5%) variants only, in particular by the well-documented protein inhibitor S and Z (PI S, PI Z) variants. Replication of the association of rs4905179 with AAT serum levels in the Copenhagen City Heart Study (N = 8273) was successful (P<0.0001), as was the replication of its synthetic nature (the effect disappeared after adjusting for PI S and Z, P = 0.57). Extending the analysis to lung function revealed a more complex situation. Only in individuals with severely compromised pulmonary health (N = 397), associations of common SNPs at this locus with lung function were driven by rarer PI S or Z variants. Overall, our meta-analysis of lung function in ever-smokers does not support a functional role of common SNPs in the SERPINA gene cluster in the general population.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publikationstyp
Artikel: Journalartikel
Dokumenttyp
Wissenschaftlicher Artikel
Typ der Hochschulschrift
Herausgeber
Schlagwörter
Genome-wide Association ; Obstructive Pulmonary-disease ; Air-flow Obstruction ; Lung-function ; Alpha-1-antitrypsin Phenotypes ; Molecular Characterization ; Mz Heterozygotes ; Rare Variants ; Alpha(1)-antitrypsin ; Population
Keywords plus
Sprache
englisch
Veröffentlichungsjahr
2013
Prepublished im Jahr
HGF-Berichtsjahr
2013
ISSN (print) / ISBN
1553-7390
e-ISSN
1553-7404
ISBN
Bandtitel
Konferenztitel
Konferzenzdatum
Konferenzort
Konferenzband
Quellenangaben
Band: 9,
Heft: 8,
Seiten: ,
Artikelnummer: e1003585
Supplement: ,
Reihe
Verlag
Public Library of Science (PLoS)
Verlagsort
Tag d. mündl. Prüfung
0000-00-00
Betreuer
Gutachter
Prüfer
Topic
Hochschule
Hochschulort
Fakultät
Veröffentlichungsdatum
0000-00-00
Anmeldedatum
0000-00-00
Anmelder/Inhaber
weitere Inhaber
Anmeldeland
Priorität
Begutachtungsstatus
Peer reviewed
POF Topic(s)
30501 - Systemic Analysis of Genetic and Environmental Factors that Impact Health
30503 - Chronic Diseases of the Lung and Allergies
Forschungsfeld(er)
Genetics and Epidemiology
PSP-Element(e)
G-504100-001
G-504200-001
G-503900-003
Förderungen
Copyright
Erfassungsdatum
2013-09-26